1 Fully Integrated Wearable Impedance Cytometry Platform on Flexible Circuit Board With Online Smartphone Readout
Angel Levine edited this page 2025-08-12 15:59:35 +08:00
This file contains ambiguous Unicode characters

This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.


The system diagram is displayed in Fig. 1. We use our custom-constructed analog architecture23, designed to detect extremely delicate impedance modifications in a microfluidic channel with low-end hardware. Custom-built analog architecture for BloodVitals SPO2 impedance cytometry with off-the shelf hardware23. System block diagram of cytometer-readout architecture. To perform conventional LIA, a voltage at a high reference frequency is modulated with the microfluidic channel impedance, producing a current sign. The biosensor used in this work depends on an electric subject generated between two electrodes within a microfluidic channel, with the baseline impedance representing phosphate buffered resolution (PBS), and variable impedance resulting from particle circulate by the electric discipline. A trans-impedance amplifier then amplifies the enter current sign and outputs a voltage sign, which is then blended with the unique reference voltage. Finally, a low-go filter isolates the low-frequency part of the product, which is a low-noise signal proportional to the channel impedance amplitude at the reference frequency22.


As our channel impedance also varies with time, we designed the low-move filter cutoff frequency to be bigger than the inverse of the transit time of the microfluidic particle, or BloodVitals SPO2 the time it takes for the particle to transverse the field between electrodes. After performing conventional LIA on our biosensor, there stays a DC offset inside the filtered sign which is along with our time-various sign of curiosity. The DC offset limits the achieve that may be applied to the sign before clipping occurs, BloodVitals SPO2 and in23, we describe the novel use of a DC-blocking stage to subtract the offset and apply a post-subtraction excessive-acquire amplification stage. The result's a extremely sensitive structure, which could be carried out with a small footprint and off-the-shelf parts. For an in-depth evaluation on the structure, BloodVitals tracker together with the noise evaluation and simulation, BloodVitals SPO2 we confer with the unique work23. An vital notice is that the DC-blocking stage causes the optimistic voltage peak to be followed by a negative voltage peak with the same integrated energy, BloodVitals SPO2 giving the novel architecture a uniquely formed peak signature.


Because the analog sign has been amplified over a number of orders of magnitude, a low-finish ADC in a microcontroller chip can sample the info. The microcontroller interfaces with a Bluetooth module paired with a custom developed smartphone application. The appliance is used to initiate information sampling, and for knowledge processing, readout and BloodVitals SPO2 evaluation. We have now applied the architecture as a seamless and wearable microfluidic platform by designing a flexible circuit on a polyimide substrate within the form of a wristband (manufactured by FlexPCB, Santa Ana, BloodVitals SPO2 device CA, USA) as proven in Fig. 2. All components, such because the batteries, microcontroller, Bluetooth module, and biochip are unified onto one board. The flexible circuit is a two-layer polyimide board with copper traces totaling an area of eight in². Surface-mount-packaged components had been selected to compact the general footprint and reduce noise. Lightweight coin cell lithium ion polymer (LIPO) batteries and regulator chips (LT1763 and LT1964 from Linear Technology) were used to offer ±5 V rails.


A 1 MHz AC crystal oscillator (SG-210 from EPSON), D flip-flop (74LS74D from Texas Instruments) for frequency division, and passive LC tank was used to generate the 500-kHz sine wave 2 Volt Peak-to-Peak (Vp-p) sign, which is excited via the biosensor. The glass wafer performing because the substrate for the biosensor was cut around the PDMS slab with a diamond scribe to minimize the dimensions and was attached to the board via micro-hook-tape and micro-loop-tape strips. The electrodes of the sensor interfaced with the board by way of leaping wires which have been first soldered to the circuits terminals after which bonded to the sensors terminals with conductive epoxy. Removal of the PDMS sensor includes de-soldering the jumping wires from the circuit board, separation of the micro-hook strip adhered to PDMS sensor from the underlying micro-loop strip adhered to the board, and vice versa for BloodVitals SPO2 the addition of another sensor. A DC-blocking capacitor BloodVitals SPO2 was added previous to the biosensor to stop low-frequency energy surges from damaging the biosensor whereas the circuit was being switched on or off.


The trans-impedance stage following the biosensor BloodVitals SPO2 was applied with a low-noise operational amplifier (TL071CP from Texas Instruments) and a potentiometer in the suggestions path for adjustable gain from 0.04 to 0.44. Mixing was achieved with a multiplier (AD835 from Analog Devices). To isolate the element of curiosity from the product of the mixing stage, a third order Butterworth low-cross filter with a 100 Hz cutoff frequency and 60 dB roll off per decade was designed with one other TL071CP op-amp23. A DC-blocking capacitor was used for the DC-blocking stage. The last stage of the analog design, the high gain stage, was achieved with two more TL071CP amplifiers. An ATtiny 85 8-bit microcontroller from Atmel driven by an exterior sixteen MHz on-board crystal was used to sample information. The HM-10 Bluetooth Low Energy (BLE) module was used for knowledge transmission to the smartphone, with the module and the breakout circuit built-in on-board. The process used to microfabricate our PDMS microfluidic channel for impedance cytometry is a regular one and has been previously reported27.